Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

Literature DB >> 23352523

Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

Stephen A Tilles¹, Larry Borish, Joshua P Cohen.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23352523 PMCID： PMC3558922 DOI： 10.1016/j.anai.2012.11.014

Source DB: PubMed Journal: Ann Allergy Asthma Immunol ISSN： 1081-1206 Impact factor: 6.347

× No keyword cloud information.

39 in total

1. The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels.

Authors: W F Rosse; G L Logue; H R Silberman; M M Frank
Journal: Trans Assoc Am Physicians Date: 1976

2. A new generation of hereditary angioedema treatments: remarkable advances clash with disturbing economic reality.

Authors: Stephen A Tilles; Larry Borish
Journal: Ann Allergy Asthma Immunol Date: 2011-04 Impact factor: 6.347

3. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.

Authors: Bruce L Zuraw; Ira Kalfus
Journal: Am J Med Date: 2012-07-14 Impact factor: 4.965

4. Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study.

Authors: G Blohmé
Journal: Acta Med Scand Date: 1972-10

5. Ecallantide for the treatment of acute attacks in hereditary angioedema.

Authors: Marco Cicardi; Robyn J Levy; Donald L McNeil; H Henry Li; Albert L Sheffer; Marilyn Campion; Patrick T Horn; William E Pullman
Journal: N Engl J Med Date: 2010-08-05 Impact factor: 91.245

6. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.

Authors: Bruce L Zuraw; Paula J Busse; Martha White; Joshua Jacobs; William Lumry; James Baker; Timothy Craig; J Andrew Grant; David Hurewitz; Leonard Bielory; William E Cartwright; Majed Koleilat; Walter Ryan; Oren Schaefer; Michael Manning; Pragnesh Patel; Jonathan A Bernstein; Roger A Friedman; Robert Wilkinson; David Tanner; Gary Kohler; Glenne Gunther; Robyn Levy; James McClellan; Joseph Redhead; David Guss; Eugene Heyman; Brent A Blumenstein; Ira Kalfus; Michael M Frank
Journal: N Engl J Med Date: 2010-08-05 Impact factor: 91.245

7. Patient access to new cancer drugs in the United States and Australia.

Authors: Andrew Wilson; Joshua Cohen
Journal: Value Health Date: 2011-07-29 Impact factor: 5.725

8. New therapies for hereditary angioedema: disease outlook changes dramatically.

Authors: Michael M Frank; Haixiang Jiang
Journal: J Allergy Clin Immunol Date: 2008-01 Impact factor: 10.793

9. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Authors: Timothy J Craig; Robyn J Levy; Richard L Wasserman; Againdra K Bewtra; David Hurewitz; Krystyna Obtułowicz; Avner Reshef; Bruce Ritchie; Dumitru Moldovan; Todor Shirov; Vesna Grivcheva-Panovska; Peter C Kiessling; Heinz-Otto Keinecke; Jonathan A Bernstein
Journal: J Allergy Clin Immunol Date: 2009-09-19 Impact factor: 10.793

Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

1. The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels.

2. A new generation of hereditary angioedema treatments: remarkable advances clash with disturbing economic reality.

3. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.

4. Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study.

5. Ecallantide for the treatment of acute attacks in hereditary angioedema.

6. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.

7. Patient access to new cancer drugs in the United States and Australia.

8. New therapies for hereditary angioedema: disease outlook changes dramatically.

9. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

10. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.

Review 1. Hereditary angioedema: imaging manifestations and clinical management.

Review 2. The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema.

Review 3. Hereditary Angioedema: The Economics of Treatment of an Orphan Disease.

4. Are payers treating orphan drugs differently?